1.
Malaysian Journal of Dermatology
; : 49-51, 2021.
Artículo
en Inglés
| WPRIM
| ID: wpr-961818
RESUMEN
Summary@#Treatment of refractory cutaneous lupus is challenging. When conventional therapy, including hydroxychloroquine (HCQ), corticosteroids and immunosuppressants, has failed, the addition of quinacrine may be a promising option. We describe a case of refractory chronic cutaneous lupus erythematosus (CCLE) who responded well to quinacrine.